To cite this paper use one of the standards below:
Colorectal cancer (CRC) is the third most frequently diagnosed malignancy and the second leading cause of cancer-related mortality worldwide. Epidemiological studies consistently associate high consumption of red and processed meat with an increased risk of CRC development and progression. One proposed mechanism underlying this association is the dietary intake of N-glycolylneuraminic acid (Neu5Gc), a non-human sialic acid abundant in red meat. Due to an inactivating mutation in the CMAH gene, humans are unable to synthesize Neu5Gc and instead produce only N-acetylneuraminic acid (Neu5Ac). Nevertheless, Neu5Gc is metabolically incorporated into human glycoconjugates through the diet, accumulating in normal tissues and at even higher levels in carcinomas. Our group previously demonstrated that Neu5Gc incorporation enhances Wnt signaling and promotes proliferation of human CRC cells. Furthermore, Apc-mutant mice fed a Neu5Gc-rich diet develop larger and more numerous intestinal polyps, supporting a role for Neu5Gc in colorectal tumorigenesis. The Epidermal Growth Factor Receptor (EGFR) is a key regulator of cell proliferation and survival in CRC. Because EGFR is heavily glycosylated, alterations in its glycan composition may influence receptor activation and ligand interactions. HCT116 cells were exposed to Neu5Gc for 72 hours, and Neu5Gc incorporation, EGFR-ligand interaction, cell viability, and sensitivity to the EGFR inhibitor gefitinib were evaluated by flow cytometry, Western blotting, and MTT assays. Cells pretreated with Neu5Gc were also stimulated with recombinant human EGF to assess EGFR signaling. Here, we show that EGFR incorporates Neu5Gc into its glycans, prompting us to investigate the functional consequences of this modification. Neu5Gc incorporation enhanced EGFR and ERK phosphorylation following EGF stimulation, resulting in increased cell viability and reduced sensitivity to gefitinib. These findings identify Neu5Gc-mediated modulation of EGFR signaling as a novel mechanism by which red meat consumption may promote CRC progression and therapeutic resistance.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper